n-formylmethionine leucyl-phenylalanine has been researched along with Multiple Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cai, HY; Chen, HH; Fu, XX; Han, S; Jiang, H; Qu, H; Wang, J | 1 |
Barnum, SR; Gay, S; Jones, JL; Müller-Ladner, U; Raine, CS; Wetsel, RA | 1 |
2 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Multiple Sclerosis
Article | Year |
---|---|
Novel nano-carriers with N-formylmethionyl-leucyl-phenylalanine-modified liposomes improve effects of C16-angiopoietin 1 in acute animal model of multiple sclerosis.
Topics: Angiopoietin-1; Animals; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Liposomes; Multiple Sclerosis; N-Formylmethionine Leucyl-Phenylalanine; Rabbits; Rats; Rats, Inbred Lew | 2023 |
Enhanced expression of chemotactic receptors in multiple sclerosis lesions.
Topics: Acute Disease; Adult; Antigens, CD; Brain Chemistry; Case-Control Studies; Chemotaxis; Chronic Disease; Complement C5a; Female; Humans; Immunohistochemistry; Male; Middle Aged; Multiple Sclerosis; N-Formylmethionine Leucyl-Phenylalanine; Receptor, Anaphylatoxin C5a; Receptors, Complement; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Interleukin; Receptors, Interleukin-8A; Receptors, Peptide; Staining and Labeling | 1996 |